Xu et al. reported a study of 1953 samples with information about NOD2 from four The Cancer Genome Atlas (TCGA) databases in 2017 and showed that NOD2 could be a predictor of survival of kidney cancer patients [15]. Here, NOD2 is linked to kidney cancer.